RéPIA - Réseau de Prévention des Infections et de l'Antibiorésistance

What RéPIA - Réseau de Prévention des Infections et de l'Antibiorésistance does

RéPIA (Réseau de Prévention des Infections et de l'Antibiorésistance) is a French national public health network established in 2018 and coordinated by Santé publique France. The network aggregates five national missions—MATIS (multimodal action boxes and impact studies), PRIMO (infection prevention in community care and nursing homes), SPARES (antibiotic consumption and resistance surveillance in healthcare establishments), SPICMI (surgical site infection prevention), and SPIADI (prevention of device-associated infections in intensive care)—covering the full patient care pathway from community medicine to hospitals and medico-social establishments. CPias Nouvelle-Aquitaine, headquartered in Bordeaux at Hôpital Pellegrin, is the host entity for the MATIS mission and the legal publisher of the preventioninfection.fr website. With approximately six core employees, the network functions as a coordination layer rather than a direct service provider.

RéPIA delivers an evidence-based resource portfolio free of charge to healthcare professionals and the general public. Core technical assets include WordPress/Elementor-based web platforms; surveillance and evaluation tools (ConsoRes, Quick EVAL Antibio, Eva-GEx, ICSHA, BUA toolkits, SPARES terminology tool); specialized training networks (JePPRI, PRI Academy); mobile applications (Recospilf on iOS and Android); and an interactive health data platform (Odisse). Communication channels span a monthly newsletter, YouTube video content (including the "Les Visages de l'antibiorésistance" patient testimonial podcast and JEPPRI TV), mission-specific webinars, social media (LinkedIn, Facebook, TikTok), and annual national campaigns such as the 5 May World Hand Hygiene Day challenge and World AMR Week. In December 2025, RéPIA launched "GPT Prévention," a generative-AI assistant, marking its first AI-native consumer-facing product.

The business model is publicly funded mandate execution, not commercial sales. RéPIA receives appropriations from Santé publique France, which awards mission mandates (e.g., the 2023-2028 SPARES mandate to a consortium of CPias and CRAtb entities). Regional CPias (Centres d'appui pour la prévention des infections associées aux soins) and CRAtb (Centres régionaux en antibiothérapie) serve as field distribution arms across France. There is no investor base, no shareholders, no commercial pricing, and no paying customers; resources are free to all end users. Strategic positioning aligns with WHO guidelines (notably World Hand Hygiene Day), HAS certification standards, and professional society partnerships (SF2H), reinforcing its role as the official national reference for infection prevention and antimicrobial resistance prevention.

Name

RéPIA - Réseau de Prévention des Infections et de l'Antibiorésistance

Legal name

CPias Nouvelle-Aquitaine - Mission MATIS - RéPIA

Website

https://preventioninfection.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

RéPIA is a French national public health network coordinated by Santé publique France, operating five missions (MATIS, PRIMO, SPARES, SPICMI, SPIADI) to prevent healthcare-associated infections and combat antimicrobial resistance across community, medico-social, and healthcare settings in France.

Ownership category

akta.pro rank

Product category

Public Health Infection Prevention Services

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Social Services (8300)

akta.pro primary industry

Public–Private Partnerships (PPPs) for Global Health (HLAJAOAD)

Keywords

• Infection prevention services
• Antimicrobial resistance surveillance
• Antibiotic stewardship tools
• Public health network
• Healthcare safety resources

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Public Health Funding: RéPIA is funded by Santé publique France as part of national public health missions. The network consists of 5 national missions (MATIS, PRIMO, SPARES, SPICMI, SPIADI) coordinated by CPias Nouvelle-Aquitaine. Resources are provided free of charge to healthcare professionals and the general public.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

RéPIA is a national public health network coordinated by Santé publique France, composed of 5 national missions (MATIS, PRIMO, SPARES, SPICMI, SPIADI) that provide free evidence-based resources, surveillance tools, training materials, evaluation tools, and awareness campaigns for the prevention of healthcare-associated infections and antimicrobial resistance across the entire patient care pathway (community care, medico-social establishments, and healthcare facilities in France).

Product overview

RéPIA is a national network coordinating 5 missions (MATIS, PRIMO, SPARES, SPICMI, SPIADI) under Santé publique France for prevention of healthcare-associated infections and antimicrobial resistance. The network operates across city medicine, nursing homes (ESMS), and healthcare establishments. Its core offerings include surveillance platforms (ConsoRes for antibiotic consumption), evaluation tools (Quick EVAL Antibio, Eva-GEx), the annual May 5th hand hygiene campaign, BUA toolkits, mobile applications (Recospilf), specialized training networks (JePPRI, PRI Academy), data platforms (Odisse), educational resources (e-Bug, Bug.Control), and communication tools (newsletter, documentary portal, social media including TikTok). The network also maintains specialized guidance for Candida auris and publishes patient awareness content including the 'Visages de l'antibiorésistance' video podcast series.

Differentiator

Problem solved

Functional benefit

Brands

• MATIS: Mission d'Appui aux Techniques et Innovations pour la Sécurité des patients - National mission for impact studies and multimodal action boxes for infection prevention.
• PRIMO
• SPARES
• SPICMI
• SPIADI

Products and services

• MATIS Mission National mission providing multimodal action boxes (BAM), evaluation tools, training resources, and impact study tools for healthcare establishments.
• PRIMO Mission National mission providing prevention tools, evaluation resources, training materials, and data visualization tools for antibiotic use in city healthcare, nursing homes, and disability facilities.
• SPARES Mission National mission providing antibiotic stewardship surveillance with tools including ConsoRes platform, Quick EVAL Antibio, Eva-GEx, and BUA toolkits for healthcare establishments.
• SPICMI Mission National mission focused on prevention of surgical site infections with audit tools (ATBP SPICMI) and national events like the May 15th Surgical Infection Prevention Day.
• SPIADI Mission National mission coordinating national seminars on device-associated infections and maintaining the SPIADI network for healthcare professionals in intensive care settings.
• Quick EVAL Antibio Web-based tool for antibiotic therapy evaluation in healthcare establishments, provided by the SPARES mission.
• ConsoRes Web platform for national antibiotic consumption surveillance data in healthcare establishments.
• Eva-GEx Evaluation tool for measuring antibiotic use in healthcare establishments.
• Recospilf Mobile Application Mobile application providing antibiotic guidelines, available for iOS and Android devices for healthcare professionals.
• JePPRI Network Specialized network for young infection prevention teams providing SCOPINARS, Biblinars, Juri'nars, and JEPPRI TV educational content for endoscopy and infection risk prevention professionals.
• PRI Academy Training platform designed for infection prevention professionals, offering educational content and skill development resources.
• Odisse Interactive data platform providing health data visualization for the public health network.
• BAM MATIS Multimodal action boxes (Boîtes d'Action Multimodales) for infection prevention impact studies in healthcare establishments.
• ICSHA Hand hygiene consumption indicator (Indicateur de Consommation de Solutions Hydro-Alcooliques) for measuring hydroalcoholic solution use in healthcare establishments.
• BUA Toolkit SPARES Comprehensive Bon Usage des Antibiotiques (BUA) toolkit with practical sheets, evaluation tools, and resources for healthcare establishments on proper antibiotic use.
• Campagne 5 Mai Annual May 5th hand hygiene campaign with the 5 days, 5 minutes, 5 challenges format including national impact study participation.
• Antibio Campaign National antibiotic awareness campaign "Antibio, ça résiste… Tous concernés, tous actifs!" with English version available for broader reach.
• Espace documentaire & Forum Documentary forum and resources portal with tutorials for accessing and sharing prevention materials among healthcare professionals.
• Newsletter RéPIA Monthly newsletter providing the latest infection prevention and antimicrobial resistance news, webinars, international updates, editorials, interviews, and videos.

Quantifiable outcome

• Annual 5 May hand hygiene campaign with national challenge participation

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• Santé publique FrancecoreStrategic or Co-development PartnerSanté publique France is the governmental agency that funds and pilots the 5 national missions of RéPIA. RéPIA operates under the coordination of Santé publique France for infection prevention and antimicrobial resistance surveillance and prevention activities across France.
• CPias Grand EstcoreStrategic or Co-development PartnerCPias Grand Est, along with CPias Nouvelle-Aquitaine, CRAtb Grand Est, and CRAtb Provence-Alpes-Côte d'Azur, was selected for the 2023-2028 mandate to carry the SPARES mission for antibiotic usage surveillance.
• World Health Organization (WHO)majorStrategic or Co-development PartnerRéPIA aligns with WHO guidelines and resources, particularly for the annual 5 May World Hand Hygiene Day campaign, using WHO-provided materials and themes.
• CPias Bretagne (National Directory)minorStrategic or Co-development PartnerCPias Bretagne hosts the national directory of CPias & CRAtb on behalf of the RéPIA network.
• HAS (Haute Autorité de Santé)majorStrategic or Co-development PartnerRéPIA coordinates with HAS for certification standards related to infection prevention and antibiotic stewardship in healthcare establishments.
• SF2H (Société Française d'Hygiène Hospitalière)majorStrategic or Co-development PartnerSF2H collaborates with RéPIA on conferences, surveys (such as COPERMIC on carbapenemase-producing bacteria), and professional training in infection prevention.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Swissnoso: Swiss national center for infection prevention and patient safety that coordinates surveillance of healthcare-associated infections and antimicrobial resistance across Swiss hospitals. Highly comparable in scope and structure to RéPIA's PRIMO and SPARES missions.

Broad incumbents

• UK Health Security Agency (UKHSA): UK's national public health body for infectious disease preparedness and response, including antimicrobial resistance programs. Operates with comparable national-level coordination mandate and surveillance infrastructure that mirrors RéPIA's mission structure.
• Public Health Agency of Canada (PHAC): Canadian federal agency responsible for public health, including the Canadian Nosocomial Infection Surveillance Program (CNISP) and antimicrobial resistance coordination, mirroring RéPIA's national coordination role.
• RIVM (National Institute for Public Health and the Environment): Dutch national public health institute coordinating infectious disease surveillance, antimicrobial resistance programs (SO-ZI/AMR), and IPC guidance across healthcare settings in the Netherlands - directly comparable mission to RéPIA.
• Robert Koch Institute (RKI): Germany's federal public health institute responsible for disease surveillance and prevention, including hospital infection surveillance and antibiotic resistance monitoring programs that parallel PRIMO, SPARES, and SPIADI missions.
• European Centre for Disease Prevention and Control (ECDC): EU agency coordinating surveillance and response to infectious diseases across Europe, with specific mandates on healthcare-associated infections and antimicrobial resistance that overlap directly with RéPIA's scope at a supranational level.
• Centers for Disease Control and Prevention (CDC): US federal agency with extensive healthcare-associated infection and antimicrobial resistance programs (NHSN, AR Lab Network). Operates at vastly larger scale but represents the closest international reference model for RéPIA's coordination of IPC/AMR missions.
• Santé publique France (French Public Health Agency): The parent entity and French national public health agency that funds and pilots RéPIA's 5 missions. It operates at broader national scope (epidemiology, vaccination, environmental health) and serves as the convening authority that coordinates RéPIA's mission-level activities.

Others

• World Health Organization (WHO): Global health authority that publishes IPC and AMR guidelines (which RéPIA aligns with), coordinates World Hand Hygiene Day and World AMR Awareness Week. Functions as a standards-setter and partner rather than direct competitor, but the most influential peer in the same thematic space.
• Haute Autorité de Santé (HAS): French national health authority that sets certification standards for healthcare establishments, which RéPIA's surveillance tools and resources are designed to support. Operates as a partner and standards-body within the same French healthcare ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights1 record

Customer concentration

• Xx.com/Prev_Infection
• YouTubeyoutube.com/channel/UCtoaiV7W5P8Q3a0xPGt5Lhw
• Facebookfacebook.com/PreventionInfection
• LinkedInlinkedin.com/company/preventioninfection
• TikToktiktok.com/@preventioninfection?lang=fr

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RéPIA - Réseau de Prévention des Infections et de l'Antibiorésistance